A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
Saracco G, Ciancio A, Olivero A, Smedile A, Roffi L, Croce G, Colletta C, Cariti G, Andreoni M, Biglino A, Calleri G, Maggi G, Tappero GF, Orsi PG, Terreni N, Macor A, Di Napoli A, Rinaldi E, Ciccone G, Rizzetto M.
Saracco G, et al. Among authors: olivero a.
Hepatology. 2001 Jul;34(1):133-8. doi: 10.1053/jhep.2001.25636.
Hepatology. 2001.
PMID: 11431744
Clinical Trial.